Tek/Tie2 is an endothelial cell-speci®c receptor tyrosine kinase that has been shown to play a role in vascular development of the mouse. Targeted mutagenesis of both Tek and its agonistic ligand, Angiopoietin-1, result in embryonic lethality, demonstrating that the signal transduction pathway(s) mediated by this receptor are crucial for normal embryonic development. In an attempt to identify downstream signaling partners of the Tek receptor, we have used the yeast two-hybrid system to identify phosphotyrosine-dependent interactions. Using this approach, we have identi®ed a novel docking molecule called Dok-R, which has sequence and structural homology to p62 dok and IRS-3. Mapping of the phosphotyrosine-interaction domain within Dok-R shows that Dok-R interacts with Tek through a PTB domain. Dok-R is coexpressed with Tek in a number of endothelial cell lines. We show that coexpression of Dok-R with activated Tek results in tyrosine phosphorylation of Dok-R and that rasGAP and Nck coimmunoprecipitate with phosphorylated Dok-R. Furthermore, Dok-R is constitutively bound to Crk presumably through the proline rich tail of Dok-R. The cloning of Dok-R represents the ®rst downstream substrate of the activated Tek receptor, and suggests that Tek can signal through a multitude of pathways.
Introduction
During embryonic development, the cardiovascular system is the ®rst organ system to form, and this is accomplished through two dierent processes ± vasculogenesis and angiogenesis. Vasculogenesis is the formation of discrete blood vessels in situ from endothelial cell precursors, and angiogenesis is the formation of blood vessels by sprouting and extending from pre-existing vessels (reviewed in Risau, 1997; Hanahan, 1997) . Vasculogenesis is responsible for the larger vascular network, including the dorsal aorta and the yolk sac, while angiogenesis is required for the vascularization of organs such as the brain and kidney, as well as the remodeling of capillary networks. Angiogenesis is required in the adult for such processes as wound healing, follicular development, and tumor growth.
The primary mechanisms that control vasculogenesis and angiogenesis are beginning to be elucidated. A number of receptor tyrosine kinases (RTKs) have been identi®ed whose expression is almost exclusively restricted to cells of the endothelial lineage (reviewed in Mustonen and Alitalo, 1995) . They play a crucial role in the development of the embryonic cardiovascular system, and they are also involved in angiogenesis in normal physiological and pathological processes. These RTKs are expressed in dierent spatial and temporal patterns during development (Dumont et al., 1995) , suggesting that they play distinct roles within the endothelial cell lineage. This subgroup of RTKs has been placed into two subfamilies according to similarities in their primary amino acid sequences (Dumont et al., 1993; Mustonen and Alitalo, 1995) . The ®rst subfamily contains the high anity vascular endothelial growth factor receptors (VEGFRs), known as Flk-1/KDR/VEGFR2, Flt-1/VEGFR1, and Flt-4/ VEGFR3, and the second subfamily consists of the TIE receptors, known as Tie/Tie1 and Tek/Tie2. Tie remains an orphan receptor while the ligands for Tek have recently been identi®ed as Angiopoietin-1 and -2 Maisonpierre et al., 1997) . Targeted null mutations in all of these receptors result in embryonic lethality (Shalaby et al., 1995; Fong et al., 1995; Dumont et al., in prep.; Dumont et al., 1994; Sato et al., 1995; Puri et al., 1995) , and the lethal phenotype is distinct for each receptor. These results suggest that the signaling pathways that are mediated by these receptors play unique roles in development.
The Tek receptor is ®rst expressed around day 7.5 during mouse development, and it is expressed by endothelial precursors and by the endothelium of actively growing blood vessels (Dumont et al., 1992; Sato et al., 1993) . Tek has recently been shown to be expressed at relatively high levels in the quiescent vasculature of a number of adult tissues as well as in healing skin wounds (Wong et al., 1997) . Interestingly, Tek immunoprecipitated from these quiescent and angiogenic tissues was found to be tyrosine phosphorylated, suggesting a dual role for this receptor in adult tissues. Mutational analysis of the tek locus by gene targeting has demonstrated that Tek is required for the maintenance of endothelial cells, since null mice exhibit a dramatic reduction in the number of endothelial cells and they die around embryonic day 9.5 ± 10.5 due to malformations of the vascular network (Dumont et al., 1994; Sato et al., 1995) . Furthermore, overexpression of activated Tek in the adult leads to a hyperproliferation of endothelial cells which results in venous malformations (Vikkula et al., 1996) . In this instance, when the proliferation is not coupled with the growth of smooth muscle cells, abnormal vessel sprouting and paracrine relationship between the receptor and its ligand . Interestingly, mice engineered to lack Angiopoietin-1 display angiogenic de®cits that are strikingly similar to those observed in mice lacking Tek and they also result in embryonic lethality (Suri et al., 1996) . In contrast to Angiopoietin-1, a second angiopoietin named Angiopoietin-2 has been isolated. Angiopoietin-2 possesses an antagonistic activity towards Tek (Maisonpierre et al., 1997) and transgenic mice engineered to overexpress Angiopoietin-2 under the control of the Tek promoter also have vascular defects which resemble the Tek null mutant. These results con®rm the prediction that signaling pathways downstream of Tek are required for normal vascular development, and that any alterations in the signaling pathway result in venous malformations or embryonic lethality.
Signaling by RTKs involves ligand binding followed by receptor dimerization and phosphorylation on tyrosine residues (reviewed in Van der Geer and Lindberg, 1994) . This autophosphorylation creates high anity binding sites for speci®c intracellular signaling molecules which contain motifs that recognize phosphotyrosine, namely SH2 (src homology 2) and PTB (phosphotyrosine binding) domains (reviewed in Pawson, 1995) . These intracellular molecules may also serve as substrates for the autophosphorylated receptors. It is assumed that Tek will also transduce its signals by phosphorylating tyrosine residues of intracellular signaling molecules since mice engineered to lack Tek kinase activity produce the same phenotype as mice lacking the entire Tek protein (Dumont et al., 1994; Koblizek et al., 1997) .
Since the ligands for Tek have only recently been identi®ed, there is little evidence contributing to our understanding of Tek-mediated signaling pathways. Huang et al. (1995) have identi®ed two signaling molecules, Grb2 and Shp-2, that could associate with phosphorylated Tek in vitro. In order to further dissect the Tek signaling pathway in the absence of Angiopoietin-1, we have used the yeast two-hybrid system to identify novel proteins that interact with the cytoplasmic domain of the activated murine Tek receptor. We identi®ed a novel docking molecule that shows homology to the recently cloned p62
dok and insulin receptor substrate-3 (IRS-3). We termed this related protein Dok-R and show that it interacts with Tek in an activation-dependent manner through a PTB domain both in vitro and in vivo. We also show that Tek can use Dok-R as a substrate both in vitro and in vivo and that once Dok-R is phosphorylated, it can interact with rasGAP and Nck. Furthermore, Dok-R is constitutively bound to Crk regardless of its phosphorylation state. Our results indicate that, using an overexpression system to activate Tek, signaling from Tek can be ampli®ed by a novel docking molecule, Dok-R.
Results

Identi®cation of a novel Tek binding protein, Dok-R
As an approach to identify molecules that are involved in Tek signaling pathways, we have used the yeast twohybrid system to ®nd proteins that can interact with the intracellular domain of Tek in a phosphotyrosinedependent manner (Fields and Song, 1989; Chien et al., 1991; O'Neill et al., 1994; Pandey et al., 1994) . The entire intracellular domain of the murine receptor (amino acids 780 ± 1122) (Tek IC ) was fused in-frame to the DNA binding domain of the Escherichia coli (E. coli) LexA transcriptional activator and this resulted in constitutive tyrosine phosphorylation of the fusion protein ( Figure 1a) . In order to screen for phosphotyrosine-dependent interactions, another fusion protein encoding a catalytically inactive form of Tek was generated through site-directed mutagenesis of the conserved ATP binding site of the kinase domain (Dumont et al., 1994) . This mutant is herein denoted Tek A853 and the corresponding intracellular portion is referred to as Tek A853IC . The activated receptor was used to screen for interacting proteins expressed from cDNAs obtained from a day 12.5 mouse embryonic heart and lung library. Several clones were identi®ed which could interact with Tek in a phosphotyrosinedependent manner and one of these clones represented a portion of a novel cDNA (Figure 1b) . Additional cDNA sequence was obtained by screening a murine adult spleen cDNA library and by 5' RACE on cDNAs derived from spleen, heart and kidney tissues.
PTB-domain
Sequence analysis of several overlapping clones revealed a putative initiator methionine embedded within a good Kozak consensus (Kozak, 1986) followed by a continuous open reading frame and a poly(A) tract (Figure 1c ). Conceptual translation of this cDNA predicts a 412 amino acid protein with a relative molecular mass of 45K. A search for similar sequences within GenBank revealed that this cDNA has 40% similarity at the amino acid level to the recently identi®ed rasGAP binding protein, p62
dok (Carpino et al., 1997; Yamanashi and Baltimore, 1997 ) and hence we have called this cDNA Dok-R, for Dok-Related. p62 dok and Dok-R also show structural homology to the newly cloned insulin receptor substrate-3 (IRS-3) adapter molecule (Lavan et al., 1997) . Functional deletion analysis of the Dok-R cDNA demonstrated that a small region encompassing amino acids 141 ± 271 is sucient for binding to Tek IC in yeast (Figure 1d ). This region shows sequence conservation with the minimal domain required for phosphotyrosine binding in the insulin receptor substrate-1 (IRS-1) (O'Neill et al., 1994; Gustafson et al., 1995) and it also possesses the critical arginine residues thought to contact phosphotyrosine in the IRS-family PTB domains (Eck et al., 1996; Zhou et al., 1996) (Figure 1e ). The phosphotyrosine binding (PTB) domains of Shc and IRS-1 have been shown to bind to NPXY motifs in target proteins (Kavanaugh et al., 1995; Wolf et al., 1995; Gustafson et al., 1995) ; however, the Tek receptor does not contain such a sequence motif suggesting that the PTB domain of Dok-R may recognize a dierent target amino acid sequence.
The pleckstrin homology (PH) and PTB domains of Dok and Dok-R share the greatest amount of sequence similarity at 48 and 58%, respectively (Figure 1e and not shown). The sequences following the PTB domain have only limited similarity throughout and these sequences are rich in proline and tyrosine residues. Dok-R contains a total of 13 tyrosine residues and many of these tyrosine residues are embedded within the appropriate context to potentially serve as docking sites for the SH2 domains of rasGAP, Crk, Abl, Src, Shp-2, Nck and others (reviewed in Songyang and Cantley, 1995) . Additionally, a number of the proline residues are found in a PXXP context, suggesting that Dok-R can also interact with SH3 (src homology 3) domain-containing proteins (reviewed in Pawson and Scott, 1997) . Taken together, the overall composition of Dok-R suggests that it can interact with a wide array of signaling molecules, and it could potentially mediate signaling from the activated Tek receptor to a number of downstream targets in endothelial cells, similar to IRS-1 in insulin signaling (reviewed in Yenush and White, 1997) .
Dok-R is co-expressed in dierent tissues and cell lines with Tek
Northern blot analysis of RNA taken from adult mouse tissues showed that Dok-R is found primarily in heart, spleen, and lung ( Figure 2a ). It is expressed weakly in the liver, skeletal muscle, kidney and testis, and there is no detectable expression in the brain. There are two predominant transcripts of approximately 2.0 and 3.0 kb in all positive tissues and a third minor transcript of 4.0 kb in the kidney and testis. The complete reading frame for Dok-R can be accounted for in the 2.0 kb transcript, such that the other two transcripts may represent alternative splicing or a related gene. To address the issue of a related gene, we reprobed the blot with a probe derived from the 3' untranslated region of Dok-R and this gave an identical expression pro®le, suggesting that the three transcripts are indeed derived from the same gene (data not shown).
In order to study the signaling properties of Dok-R, we generated two dierent antibodies against Dok-R. The ®rst antibody was raised against a fusion protein between glutathione S-transferase (GST) and the entire Dok-R protein without the PH domain (aDok-R) and the second antibody was raised against a synthetic peptide corresponding to the last 25 amino acids of Dok-R (aDok-R CT ). These antibodies were used to detect the Dok-R protein in lysates from human embryonic kidney (HEK) 293T cells transiently transfected with Dok-R cDNA. Western blotting results show that Dok-R migrates at 56K, which is well above its predicted size ( Figure 2b ). This aberrant gel mobility was also reported for p62 dok and it is likely due to the high proline content of these proteins. The speci®city of the antisera was con®rmed since there were no reactive species detected with pre-immune sera (data not shown). Whole cell lysates prepared from various tissues and endothelial cell lines were resolved and immunoblotted with the same antibodies ( Figure  2b ). These results show that endogenous Dok-R also migrates at 56K, demonstrating that our cDNA represents the full coding region of Dok-R. These antibodies also recognize a larger protein of 72K and it may represent another isoform of Dok-R, perhaps the result of the 3.0 kb transcript, or it may be a related protein that is also recognized by our anti-Dok-R antibodies. In summary, these results show that Dok-R can be found in a number of tissues that are rich in endothelial cells as well as in a number of cultured endothelial cell lines that have been shown to express Tek (Dumont et al., 1993 ; SVR data not shown).
To further demonstrate that Tek and Dok-R are coexpressed within endothelial cells, we used anity puri®ed Dok-R antibody in conjunction with a marker for endothelial cells, platelet and endothelial cell adhesion molecule-1 (PECAM-1) (MEC 13.3) (Vecchi et al., 1994) , in coimmuno¯uorescence studies on thin Tek/Tie2 signaling through Dok-R N Jones et al sections taken from day 15.5 embryos. Figure 2c illustrates that expression of Dok-R, which can be visualized by green¯uorescence (FITC) in the developing myocardium and trabeculae of the heart in panels (a) and (b), overlaps in part with the expression of PECAM-1, which is visualized by red uorescence (Cy3) in panels (a') and (b'). Overlapping expression patterns can be visualized as orangē uorescence (FITC+Cy3) in panel (b+b'), demonstrating that Dok-R is expressed in endothelial cells and that expression of Dok-R is not restricted to endothelial cells.
The PTB domain of Dok-R mediates binding to phosphorylated Tek
The deletion analysis performed in yeast suggests that it is the PTB domain of Dok-R which mediates binding to Tek. In order to determine whether this region can mediate binding outside of the yeast environment, we fused the PTB domain of Dok-R to GST and puri®ed this fusion protein from E. coli. Immobilized GST-Dok-R-PTB was incubated with lysates from 293T cells that transiently express the hemagglutinin (HA)-tagged cytoplasmic domains of either a constitutively phosphorylated form of Tek (Tek IC ) or a kinase inactive, non-phosphorylated form (Tek A853IC ) (Figure 3a) . Overexpression of these truncated proteins allows for the study of activated Tek in the absence of Angiopoietin-1. Proteins bound to GST-Dok-R-PTB were immunoblotted for the presence of Tek. Figure 3b demonstrates that Tek IC can be precipitated from cell lysates by the PTB domain of Dok-R and that this association is dependent upon the phosphorylation state of Tek. These results demonstrate that the Dok-R PTB domain is able to bind speci®cally to Tek in vitro and that this interaction is Tek tyrosine kinase activation-dependent.
In vivo association of Dok-R and Tek in 293T cells
To further determine whether the association we detected in yeast and in vitro could occur in vivo, we transiently expressed either Tek or Tek A853 with Dok-R in 293T cells. Overexpression of full-length Tek in 293T cells results in its tyrosine phosphorylation (Figure 3c ). This phosphorylation is dependent upon a functional Tek kinase domain suggesting that the sites that are phosphorylated under these conditions are de®ned by the speci®city of the Tek kinase domain and as such should re¯ect the sites that are normally phosphorylated upon ligand stimulation. However, we cannot rule out the possibility that this pattern of phosphorylation would not be recapitulated under conditions of Angiopoietin-1 stimulation in vivo. Lysates were c αDOK-R αPECAM αDOK-R + αPECAM ) demonstrate that Dok-R encodes a protein with an apparent molecular weight of 56K in SDS ± PAGE. A second reactive species is detected by these antibodies (72K) and this could be either a second isoform of Dok-R or a related protein. Fliver, E12.5 fetal liver; Fheart & Lung, E12.5 fetal heart and lung. (c) Indirect immuno¯uorescence was performed on midsaggital thin sections cut from E15.5 embryos. A high magni®cation of the heart region is shown. Low level Dok-R expression (green¯uorescence) can be seen throughout the myocardium (Myo) and the trabeculae (T). The highlighted area is further magni®ed in (b). Expression of the endothelial marker PECAM-1 (red¯uorescence) can be detected in the endothelium in (a') and in the magni®ed region in (b'). Overlap of Dok-R and PECAM-1 expression can be visualized by orange¯uorescence in endothelial cells in (b+b') prepared from these transfected cells and immunoprecipitated with an antibody speci®c for Dok-R. Coprecipitation of Tek with Dok-R was only observed when Tek was phosphorylated, demonstrating that Dok-R can associate with Tek in vivo and that the interaction is dependent upon Tek kinase activity (Figure 3c ).
Tek can phosphorylate Dok-R in vitro and in vivo A number of receptors once activated will utilize the proteins bound to them as substrates. For instance, when the insulin receptor is stimulated by insulin, it speci®cally recruits the docking molecule IRS-1 through its PTB domain and subsequently phosphorylates IRS-1 on tyrosine residues (Sun et al., 1993) . In addition, the epidermal growth factor (EGF) receptor can use the adapter molecules Shc and Gab1 as substrates when stimulated (Pelicci et al., 1992; Holgado-Madruga et al., 1996) . To demonstrate that Tek could utilize Dok-R as a substrate, we immunoprecipitated full-length activated Tek from Tektransfected 293T cell lysates and performed in vitro kinase assays using either GST or GST-Dok-R as substrates. A Tek immunoprecipitate was able to phosphorylate the recombinant GST-Dok-R whereas no phosphorylation of GST alone was detected ( Figure  4a ).
To determine whether Tek could utilize Dok-R as an in vivo substrate, we immunoprecipitated Dok-R from cells transfected with either Dok-R alone or in combination with Tek or Tek
A853
. Proteins from these immunoprecipitates were resolved and immunoblotted for the presence of phosphotyrosine. Figure 4b demonstrates that Dok-R is only tyrosine phosphorylated in the presence of a kinase active form of Tek. Dok-R coimmunoprecipitation with the phosphorylated receptor can also be seen here. Although we cannot rule out the possibility that activation of Tek results in the stepwise activation of another kinase which is responsible for the phosphorylation of Dok-R, our in vitro and in vivo data suggests that upon recruitment of Dok-R to phosphorylated Tek, Tek is able to utilize Dok-R as a substrate and subsequently cause its tyrosine phosphorylation. Pawson and Scott, 1997) . This phosphorylation by the receptor establishes high anity binding sites for these proteins. Scanning the sequence of Dok-R for potential binding sites revealed that Dok-R contains three potential rasGAP, Crk, and Nck binding sites (YXXP) (Songyang et al., 1993) . To determine whether phosphorylation by Tek establishes binding sites for these SH2-containing proteins in vivo, we expressed either Dok-R alone or in combination with Tek or Tek A853 in 293T cells. Lysates from these transfected cells were immunoprecipitated with an antibody speci®c for Dok-R, and the resulting complexes were resolved and immunoblotted with various antibodies. These results show that both rasGAP and Nck can coimmunoprecipitate with Dok-R in a phosphorylation-dependent manner, while Crk . A synthetic phosphopeptide corresponding to this region of Dok-R (tyrosine residue 351 (pY351)) was able to precipitate Nck from ®broblast lysates whereas an unphosphorylated peptide (Y351) was not. WCL, whole cell lysate Tek/Tie2 signaling through Dok-R N Jones et al can coimmunoprecipitate with Dok-R regardless of its phosphorylation state (Figure 4c ). These results suggest that the interaction of both rasGAP and Nck with Dok-R is likely mediated by their SH2 domains with phosphotyrosine residues on Dok-R, while the interaction between Crk and Dok-R is likely constitutive through one of the SH3 domains of Crk and a proline rich sequence of Dok-R. Interestingly, Dok and Dok-R show striking homology in a small area of their carboxyl region (Figure 4d ). In fact, this homology is conserved in both human and murine Dok and Dok-R proteins (not shown), suggesting that this region plays an important role in their signaling. The tyrosine residue in this region is found within a predicted SH2-binding site for Nck (YDEP). Using phosphorylated and unphosphorylated biotinylated peptides corresponding to the region surrounding tyrosine residue 351 (Y351) of Dok-R, we demonstrated that the phosphorylated peptide derived from this highly conserved region will mediate the binding of Nck to Dok-R while the unphosphorylated peptide will not (Figure 4d ). This result suggests that signaling through Nck is likely a common feature in this newly emerging family of docking molecules. Taken together, these results show that phosphorylation of Dok-R by Tek enables it to function as a docking molecule during Tek signaling through its interactions with a number of downstream signaling molecules.
Discussion
In this study, we describe the identi®cation of a novel docking molecule, Dok-R, which can interact in a phosphorylation-dependent manner with the endothelial receptor, Tek. The binding of Dok-R to Tek both in yeast and in vitro was mediated through a region of Dok-R which shows homology to the PTB domains of Dok and IRS-1. Dok-R also contains an aminoterminal PH domain and this is likely involved in recruitment of Dok-R to the cell membrane. Dok-R becomes tyrosine phosphorylated in the presence of an activated Tek receptor, and this is the ®rst reported substrate of the Tek receptor. Phosphorylation of Dok-R establishes binding sites for rasGAP and Nck and Dok-R is constitutively associated with Crk. In summary, these results present evidence to suggest that Dok-R functions as a novel docking molecule that can link the activated Tek receptor to a number of dierent signaling pathways.
Dok-R contains a central PTB domain which is essential for its binding to the Tek receptor in vitro. Sequence analysis of this PTB domain shows that it is related to the PTB domain of IRS-1, and it contains the critical arginine residues that have been shown to contact the phosphotyrosine residue in the target binding site. It is interesting to note that the Tek receptor does not contain the reported consensus target sequence, NPXY. A similar paradigm has been reported for the ®broblast growth factor (FGF) receptor and its newly de®ned substrate, FGF receptor substrate 2 (FRS2) (Kouhara et al., 1997) . FRS2 contains a putative PTB domain that is also related to the PTB domain of IRS-1 and, although it is not clear whether the interaction between the FGF receptor and FRS2 is direct, the FGF receptor does not contain an NPXY motif. Additionally, the PTB domain of Shc has been shown to interact with PTP-PEST through an NPLH motif (Charest et al., 1996) and the PTB domains of X11 and FE65 (Borg et al., 1996) have been shown to interact with non-phosphorylated NPXY motifs. Similarly, the PTB domain of Numb has been shown to interact with non-phosphorylated (Dho et al., 1998) and non-NPXY motif-containing Chien et al., 1998) targets. This suggests that the speci®city of PTB domain binding may be more dependent upon tertiary structure rather than on a linear sequence.
The amino terminus of Dok-R contains a pleckstrinhomology (PH) domain (Lemmon et al., 1996) . PH domains have been shown to mediate binding of various proteins to phosphoinositides on the inner face of the plasma membrane, thus serving as a domain to target host proteins to the membrane, presumably in the vicinity of their physiological targets. A number of docking molecules contain both a PH domain and a PTB domain, which essentially provides two contributions to membrane localization for the host protein. In the case of IRS-1, intact PH and PTB domains are required for ecient coupling of IRS-1 to the insulin receptor and tyrosine phosphorylation of IRS-1 (O'Neill et al., 1994; Gustafson et al., 1995; Yenush et al., 1996) . The role of the PH domains of Dok and Dok-R is currently unknown, although they can be expected to perform a similar function in mediating phospholipid binding and subsequent membrane targeting upon receptor stimulation.
The cloning of Dok-R marks the ®rst evidence for a downstream substrate of the activated Tek receptor. Dok-R becomes tyrosine phosphorylated in cells expressing an active Tek kinase and this phosphorylation establishes binding sites for a number of cytosolic signaling proteins that contain SH2 domains. Dok-R contains a total of 13 tyrosine residues that could potentially serve as docking sites. Our results show that phosphorylation of Dok-R in vivo creates docking sites for the SH2 domains of rasGAP and Nck. Additionally, we have shown that Dok-R is constitutively coupled to Crk, and this interaction is likely mediated by one (or more) of the six PXXP motifs in the Dok-R protein binding to one of the SH3 domains of Crk. The presence of this multitude of inducible SH2 and constitutive SH3 docking sites in the Dok-R protein suggests that Dok-R can interact with a wide array of signaling and/or scaolding proteins. Our ®ndings that Dok-R can interact with rasGAP, Nck, and Crk demonstrates that Tek-mediated signaling may proceed through a number of dierent cellular pathways which could aect cell mobility.
Nck is an SH2-and SH3-domain containing adapter protein that is expressed in a number of tissues and cell lines. The Drosophila homolog of Nck, Dreadlocks, has been shown to play an important role during axonal navigation in photoreceptor cells (Garrity et al., 1996) , but the role of Nck in mammalian cells is unclear. The SH2 domain of Nck has previously been shown to bind to phosphorylated receptors and cytoplasmic tyrosine kinases as well as to IRS-1 (reviewed in Birge et al., 1996) . In addition, the SH3 domains of Nck can constitutively couple to a number of proteins including the serine/threonine kinases NAK, PRK2, Tek/Tie2 signaling through Dok-R N Jones et al Pak1 and CKI-g2, the guanine nucleotide exchange factor, Sos, the protein product of the c-cbl protooncogene, and the Wiskott ± Aldrich syndrome protein, WASP. The interaction between Nck and this host of signaling molecules allows Nck to play a role during cellular proliferation and in the induction of actin cytoskeleton reorganization. The physiological role of the interaction between Nck and Dok-R is unclear at this stage. Since Nck has been shown to play a role in cell migration following growth factor stimulation (Rockow et al., 1996) , it is plausible that the inducible interaction between Nck and Dok-R following Tek stimulation will also aect endothelial cell migration.
Crk is an adapter protein that is dierentially spliced to contain either one or two SH3 domains in conjunction with an SH2 domain (reviewed in Matsuda and Kurata, 1996) . The SH3 domains of Crk mediate interactions with two guanine nucleotide exchange proteins, known as Sos and C3G. Sos is an exchange factor for Ras which results in activation of the mitogen activated protein kinase (MAPK) pathway and Crk has been shown to be essential for positive activation of Ras (Tanaka et al., 1993) . In contrast, C3G is an activator of Rap1, which is another Ras-family protein (Gotoh et al., 1995) . Overexpression of C3G in NIH3T3 cells cotransfected with activated Ras had a reverting eect on Rasmediated transformation, suggesting that Rap1 may act as a suppressor of Ras (Gotoh et al., 1995) . Additionally, Crk has recently been shown to activate c-Jun kinase (JNK1) through C3G (Tanaka et al., 1997) , suggesting that Crk could potentially contribute to the activation of parallel signaling pathways. Binding studies with Crk have shown that the SH2 domain of Crk associates with a number of proteins found in focal adhesion kinase (FAK) complexes (reviewed in Hanks and Polte, 1997) . Signaling through FAK aects the actin cytoskeleton to ultimately change the shape and migratory properties of cells. Whether Tek-signaling mediated through Dok-R aects any of these processes by virtue of its association with Crk is unknown.
One obvious connection between Dok-R and endothelial cell signaling can be drawn from the inducible interaction between Dok-R and rasGAP. rasGAP is a GTPase activating protein and it functions as a negative regulator of Ras signaling by stimulating the intrinsic rate of Ras GTPase activity (Trahey et al., 1988) . Deletion of the rasGAP gene (Henkemeyer et al., 1995) produces a very pleiotropic phenotype as would be expected for a key enzyme which rests downstream of multiple signaling pathways. Vascular defects observed in rasGAP-null embryos (Henkemeyer et al., 1995) resemble the loss of vascular integrity seen in both Tek-and Angiopoietin-1-null embryos (Dumont et al., 1994; Sato et al., 1995; Suri et al., 1996) . Furthermore, an abnormal endothelial cell migration pattern was observed in these embryos. Since Ras is required for the motility of cultured endothelial cells in vitro (Sosnowski et al., 1993) it is likely that this phenotype may be a result of inappropriate signaling through Ras in the endothelial cells of these embryos. The vascular defects observed in rasGAP-null embryos may in part be due to a defect in the Tek signaling pathway, since the absence of rasGAP in these endothelial cells may alter Dok-R's ability to aect changes in Ras activity following Tek stimulation.
The interaction of Dok-R with this trio of signaling molecules suggests that Tek signaling through Dok-R may ultimately lead to alterations in the intracellular architecture of endothelial cells through a number of dierent pathways. This change in cellular morphology could facilitate the directed motility/migration of endothelial cells during angiogenesis, which is a prerequisite for the sprouting process. This is supported by the fact that endothelial cells in Tekand Angiopoietin-1-null embryos are thought to have an angiogenic or migratory defect, and this is manifested as a lack of vessel sprouting (Dumont et al., 1994; Sato et al., 1995; Suri et al., 1996) .
The ability of Dok-R to interact with rasGAP, Nck and Crk suggests that it functions as a multi-site docking molecule during Tek signaling. There is also evidence to suggest that Dok may be playing a similar role as a docking molecule. Carpino et al. (1997) have shown that p62 dok becomes tyrosine phosphorylated upon c-Kit ligand stimulation of Mo7 leukemic progenitor cells and Yamanashi and Baltimore (1997) have shown that Dok binds to (and is phosphorylated by) v-Abl. Tyrosine phosphorylated Dok can then interact with rasGAP. Additionally, Dok was also phosphorylated upon stimulation of the EphB2 receptor (Holland et al., 1997) and the EGF receptor (Tang et al., 1997) and in both instances, phosphorylated Dok was associated with Nck. Taken together, this suggests that upon tyrosine phosphorylation, Dok and Dok-R may interact with a similar repertoire of downstream substrates. However, it has been reported that Crk does not associate with p62 dok (Yamanashi and Baltimore, 1997) , suggesting that Dok and Dok-R do exhibit dierent speci®cities in the molecules which they will recruit.
In conclusion, the preceding results show that upon Tek activation and phosphorylation, the receptor is able to speci®cally recruit a novel docking molecule called Dok-R. Furthermore, Tek can utilize Dok-R as a substrate in vitro and when Dok-R and Tek are coexpressed under conditions which result in the activation of Tek, Dok-R becomes tyrosine phosphorylated. This phosphorylation of Dok-R establishes high-anity binding sites for two SH2-containing proteins rasGAP and Nck, and Dok-R is constitutively bound to Crk. These experiments were accomplished in the absence of Angiopoietin-1 stimulation; however, the phosphorylation of Tek in our assay is solely dependent upon an active membrane-localized Tek enzyme suggesting that the phosphorylated residues are those which would normally be phosphorylated upon Angiopoietin-1 stimulation. The subsequent recruitment of these cytosolic proteins suggests that Tek-mediated signaling may proceed through a number of dierent pathways which allows for diversi®cation and ampli®cation of signals from Tek. The identi®cation of Dok-R and the subsequent elucidation of Tekmediated signaling pathways will contribute to our understanding of normal vascular development in both the embryo and the adult, as well as in pathological situations such as tumour-mediated angiogenesis.
Materials and methods cDNA library construction and yeast two-hybrid screening Yeast two-hybrid screening was performed using an oligo(dT)-primed cDNA library from murine embryonic day 12.5 heart and lung tissues, prepared using the HybriZAP Two-Hybrid cDNA Gigapack Cloning Kit (Stratagene). This was sequentially transformed into the L40 yeast strain expressing the cytoplasmic domain of Tek (amino acids 780 to 1122) in a modi®ed pBTM116 vector using the lithium acetate method of transformation (Gietz et al., 1992) . Approximately 10 7 transformants were plated on synthetic medium lacking tryptophan, histidine, uracil, leucine and lysine, supplemented with 20 mM 3-aminotriazole, and incubated at 308C for 5 days. His + transformants were assayed for b-galactosidase activity and putative interacting cDNAs were isolated by electroporation of yeast DNA into competent MH6 E. coli. These cDNAs were then tested to exclude any non-speci®c interactions by cotrasformation of yeast with either pBTM116 (no insert) or LexA-Lamin. Putative interacting cDNAs that were not excluded at this stage were then tested for phosphotyrosine-dependence by cotransformation with either wild type or kinase inactive Tek. cDNAs that showed blue colour speci®cally with the wild type receptor were sequenced and the identity of each sequence revealed by the on-line BLAST search engine. Following isolation of initial Dok-R cDNA, further clones were isolated from a murine adult spleen cDNA library (Stratagene) by standard DNA hybridization techniques.
Northern analysis
A mouse multiple tissue Northern blot (Clontech) was hybridized under conditions recommended by the manufacturer. Blots were hybridized with various fragments from Dok-R cDNA labeled by random primer extension (Pharmacia Biotech) using a-32 P-dCTP (Dupont NEN).
Immunohistochemistry
Embryos were obtained from ICR (Taconic) matings and the day of the vaginal plug was considered E0.5. Embryos were isolated and ®xed for 4 h at room temperature in Histochoice (Amresco) followed by¯oating in 30% sucrose overnight at 48C. Embryos were then embedded in OCT (Tissue Tek, MILES) and 10 mm thin sections were cut using a cryostat (Leica). Sections were placed on superfrost/plus slides (Fisher). Sections were ®xed for 20 min in ice cold acetone/methanol (1 : 1 v/v). Puri®ed Dok-R antibody was used at 5 mg/ml and anti-PECAM-1 (MEC 13.3, a kind gift of A Vecchi) was diluted 1 : 2000 from conditioned medium. The presence of Dok-R was visualized with FITC antirabbit secondary antibody (Jackson Immunologicals) and the presence of PECAM-1 was determined by Cy3 anti-rat secondary antibody (Jackson Immunologicals). Slides were analysed on a Leica DMR compound microscope.
Production of GST fusion proteins
The GST-Dok-R-PTB fusion protein was made by cloning amino acids 150 ± 253 into the pGEX-4T-1 vector (Pharmacia Biotech). The GST-Dok-R fusion protein used in the kinase assay and for antibody production was made by cloning amino acids 141 ± 412, the region ®rst identi®ed in yeast, into the pGEX-4T-1 vector. The GST fusion proteins were expressed in the DH5a strain of E. coli. GST fusion proteins were prepared using standard procedures and the recombinant fusion proteins were puri®ed following immobilization on glutathione-sepharose beads (Pharmacia Biotech). Puri®ed proteins were analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS ± PAGE) followed by Coomassie Blue staining. The concentrations of the proteins were estimated by comparison with bovine serum albumin (BSA) standards.
GST binding and coimmunoprecipitation assays
The cDNAs representing the cytoplasmic domain of Tek (amino acids 780 ± 1122), both wild type and kinase inactive, were subcloned into pACTag2 (a kind gift of Jane McGlade) to generate hemagglutinin (HA)-tagged proteins. The cDNA representing the full-length Tek receptor was cloned into the pRc/RSV vector (Invitrogen) and the corresponding full-length Tek A853 cDNA was cloned into pcDNA3.1(+) (Invitrogen). Ten mg of each DNA was used to transfect a 10 cm culture dish of 293T cells, using lipofectin reagent (Gibco ± BRL), according to the manufacturer's instructions. Forty-eight hours posttransfection, cells were solubilized in PLC lysis buer (50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 10 mM sodium pyrophosphate, 100 mM sodium¯uoride, supplemented with 1 mM sodium orthovanadate and Complete protease inhibitor tablets (Boehringer-Mannheim)), and cleared by centrifugation at 13 000 r.p.m. for 15 min at 48C. Cleared extracts were precipitated with 4 mg of anti-Tek antibody (C-20; Santa Cruz Biotechnology), anity puri®ed antiDok-R antibody, or puri®ed rabbit anti-mouse IgG (Upstate Biotechnology, Inc.) and recovered using protein A-sepharose beads (Sigma), or incubated with 5 mg of puri®ed GST fusion protein. The precipitated proteins were eluted in twice concentrated SDS sample buer and boiled for 10 min, separated using SDS ± PAGE and transferred to nitrocellulose ®lter using a BioRad semi-dry transfer apparatus, according to the manufacturer's instructions. Prior to immunoblotting, membranes were blocked with either 5% nonfat milk in TBST buer (10 mM Tris (pH 7.5), 150 mM NaCl and 0.1% Tween 20) or 5% BSA in TBST (for 4G10 blotting). Immobilized proteins were subjected to immunoblot analysis with various antibodies. Following peroxidase-conjugated secondary antibody incubations (BioRad) and extensive washing, membranes were developed using a chemiluminescent reaction (ECL, Amersham Corporation).
Peptide association assays
Unstimulated NIH3T3 ®broblasts were lysed in PLC lysis buer and incubated with 10 mg of biotinylated peptide for 2 h at 48C. Complexes were recovered on streptavidin agarose beads (Pierce), eluted in sample buer, and processed as described above.
In vitro kinase assay
Kinase assays were performed as described by Ziegler et al., (1993) in the presence of 1 mg of either GST or GSTDok-R fusion protein. The reactions were allowed to proceed for 15 min at 378C, and they were terminated by addition of sample buer and boiling for 10 min. The reactions were diluted to 0.1% SDS in PLC lysis buer and precleared with protein A-sepharose. Cleared lysates were then immunoprecipitated with anti-Dok-R antibodies (which also contained a signi®cant amount of anti-GST antibodies) and the immunocomplexes resolved on SDS ± PAGE. Gels were dried and exposed to X-ray ®lm.
Antibodies used for Western blotting
Commercially available antibodies used were as follows: polyclonal anti-Tek c20 antibody (Santa Cruz); monoclonal anti-phosphotyrosine antibody 4G10 (Upstate was used to raise a second polyclonal anti-Dok-R antiserum in rabbits and this antiserum was also anity puri®ed. This antibody is referred to as anti-Dok-R CT .
Cell lines and culture
Py4-1 cells have been described previously (Dubois et al., 1991) . SVR cells were obtained from ATCC while HEK 293T and NIH3T3 cells were a gift from Jane McGlade (AMGEN Institute). All cell lines were grown on 10-cm plates in Dulbecco's modi®ed Eagle's medium (Gibco ± BRL) supplemented with 10% fetal bovine serum (Gibco ± BRL), 1% penicillin, 1% streptomycin and 200 mM Lglutamine in a 378C, 5% CO 2 incubator. Cells were grown to con¯uence, washed twice in cold 16phosphate buered saline (Gibco ± BRL), and solubilized in PLC lysis buer.
Note added in proof A homolog to Dok-R, Dok-2, has recently been reported by Di Cristofano et al. (J. Biol. Chem. 273, 4827±4830).
